Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)

Summary

The primary objective of the study is to evaluate the long-term safety of UX007 in Glut1 DS participants.

Timeline

Start

2015-09-10

Primary completion

2019-10-22

Completion

2019-10-22

Drugs

Indications